The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-110
SponsorDeutsches Herzzentrum Muenchen
About this trial
Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.
Eligibility criteria
Qualifiers
Age above 18 years and consentable
Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
Written informed consent
Disqualifiers
Patient's inability to fully cooperate with the protocol
Trial design
Treatments tested in this trial
- edge-to-edge valve repair
Treatment groups
No treatment groups listed
Locations
1Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität MünchenD80636, MunichBavaria, Germany
Sponsors and collaborators
Deutsches Herzzentrum Muenchen
Lead sponsor
Source ClinicalTrials.gov